BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25758082)

  • 1. Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin.
    Hagiya H; Hasegawa K; Asano K; Terasaka T; Kimura K; Nada T; Nakamura E; Waseda K; Hanayama Y; Otsuka F
    Intern Med; 2015; 54(5):525-9. PubMed ID: 25758082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic pneumonia induced by daptomycin.
    Hayes D; Anstead MI; Kuhn RJ
    J Infect; 2007 Apr; 54(4):e211-3. PubMed ID: 17207858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin-Induced Eosinophilic Pneumonia: A Case Report and Systematic Review.
    Di Lorenzo A; Rindi LV; Campogiani L; Imeneo A; Alessio G; Pace PG; Lodi A; Rossi B; Crea AMA; Vitale P; Kontogiannis D; Malagnino V; Andreoni M; Iannetta M; Sarmati L
    Chemotherapy; 2024; 69(2):85-99. PubMed ID: 37963447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.
    Hirai J; Hagihara M; Haranaga S; Kinjo T; Hashioka H; Kato H; Sakanashi D; Yamagishi Y; Mikamo H; Fujita J
    J Infect Chemother; 2017 Apr; 23(4):245-249. PubMed ID: 28003110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports.
    Phillips J; Cardile AP; Patterson TF; Lewis JS
    Scand J Infect Dis; 2013 Oct; 45(10):804-8. PubMed ID: 23826793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.
    Rether C; Conen A; Grossenbacher M; Albrich WC
    Infection; 2011 Dec; 39(6):583-5. PubMed ID: 21717147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin-induced acute eosinophilic pneumonia.
    Patel JJ; Antony A; Herrera M; Lipchik RJ
    WMJ; 2014 Oct; 113(5):199-201. PubMed ID: 25739164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.
    Lichterfeld M; Ferraro MJ; Davis BT
    Int J Antimicrob Agents; 2010 Jan; 35(1):96. PubMed ID: 19896341
    [No Abstract]   [Full Text] [Related]  

  • 9. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
    Gomez EO; Jafary A; Dever LL
    Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.
    Durante-Mangoni E; Andini R; Parrella A; Mattucci I; Cavezza G; Senese A; Trojaniello C; Caprioli R; Diana MV; Utili R
    Int J Antimicrob Agents; 2016 Jul; 48(1):61-68. PubMed ID: 27259674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
    Yusuf E; Perrottet N; Orasch C; Borens O; Trampuz A
    Surg Infect (Larchmt); 2014 Dec; 15(6):834-7. PubMed ID: 25317960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of daptomycin in patients with renal impairment].
    Azanza JR; Quetglas EG
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():55-9. PubMed ID: 21477705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
    Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature.
    Higashi Y; Nakamura S; Tsuji Y; Ogami C; Matsumoto K; Kawago K; Tokui K; Hayashi R; Sakamaki I; Yamamoto Y
    Intern Med; 2018 Jan; 57(2):253-258. PubMed ID: 29093391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic pneumonia: Daptomycin-induced lung complication.
    Akcaer M; Karakas A; Tok D; Coskun O; Sari S
    Med Mal Infect; 2016 May; 46(3):166-8. PubMed ID: 26965755
    [No Abstract]   [Full Text] [Related]  

  • 16. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
    Levine DP; Lamp KC
    Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for daptomycin use in endocarditis and pacemaker lead infection and outcomes in Leeds, UK.
    Sandoe J; Baig W
    Future Cardiol; 2012 Jul; 8(4):547-54. PubMed ID: 22871194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin.
    Shah M; Murillo JL
    Ann Pharmacother; 2005 Oct; 39(10):1741-4. PubMed ID: 16144879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
    Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM
    Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin-associated eosinophilic pneumonia with rechallenge: a case report
.
    Nickerson M; Bhargava A; Kale-Pradhan PB
    Int J Clin Pharmacol Ther; 2017 Jun; 55(6):521-524. PubMed ID: 28406091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.